DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients-Reference-Cited by-同舟云学术

DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients

Published:2012-10 Issue:10 Volume:1 Page:e30-e30
ISSN:2157-9024
Container-title:Oncogenesis
language:en
Short-container-title:Oncogenesis

Author:

Allera-Moreau C,Rouquette I,Lepage B,Oumouhou N,Walschaerts M,Leconte E,Schilling V,Gordien K,Brouchet L,Delisle M B,Mazieres J,Hoffmann J S,Pasero P,Cazaux C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology

Link

http://www.nature.com/articles/oncsis201229.pdf

Reference51 articles.

1. Subramanian J, Simon R . Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 2010; 102: 464–474.

2. Zhu C, Ding K, Strumpf D, Weir B, Meyerson M, Pennell N et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 2010; 28: 4417–4424.

3. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT et al. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet 2012; 379: 823–832.

4. Chen DT, Hsu YL, Fulp WJ, Coppola D, Haura EB, Yeatman TJ et al. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer. J Natl Cancer Inst 2011; 103: 1859–1870.

5. Burhans WC, Carr AM, Wahl GM . DNA replication and cancer. In: DePamphilis M, (ed.). DNA replication and human disease. Cold Spring Harbor, New York, 2006.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A non-tethering role for the Drosophila Pol θ linker domain in promoting damage resolution;2024-08-27

2. Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors;Cancer Gene Therapy;2024-08-09

3. Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules;MedComm;2024-07-19

4. Single-molecule characterization of SV40 replisome and novel factors: human FPC and Mcm10;Nucleic Acids Research;2024-07-05

5. New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2024-07-02